For 69-year-old New Jersey native Rona Greenberg, cancer has always been a constant. Her mother was diagnosed with breast cancer at age 37 and passed away six years later, when Rona was 19 years old. In 1997, just three years after the BRCA genes 1 and 2 mutations were identified, Rona and her three sisters participated in a clinical study for high-risk Ashkenazi women.

“It was good I got cancer,” says Cynthia Kimball. “I thought these kinds of things happened to other people and not to me. I thought I was invincible.”

Soon after Danielle “Dee-Dee” Shiller turned 40, her best friend was diagnosed with breast cancer. Then Shiller, a gynecologist and osteopath, learned that a large Jewish family in her Baltimore practice carried the BRCA gene mutation but had no history of breast cancer.

Infographic

JScreen has made access to genetic carrier screening easier than ever. A national effort based out of Emory University’s Department of Human Genetics, the JScreen genetic screening program is the first of its kind.

In the meantime, we took Evan to see a pediatric ophthalmologist. Midway through the exam, the doctor found a cherry-red spot on his retina. This news was like having a dagger stabbed through our hearts, since this was an almost certain indicator that Evan had Tay-Sachs disease. I contacted my OB-GYN, who, upon re-examining my records, discovered that I had actually tested positive as a Tay-Sachs carrier.

Rachel Chaikof was two years old when, with the help of cochlear implants, she heard her mother’s voice for the first time. “Cry Rachel, cry Rachel, ” her mother sang, alongside Rachel’s grandmother, who clapped her hands, watching her granddaughter, born completely deaf, respond to sound. “My family and I never understood why my sister and I were born deaf,” Rachel, now 30, says, “We knew it was genetic, but we never really had an answer.”